Mebeverin Puren

Mebeverine Hydrochloride, the active ingredient in Mebeverin Puren, is an antispasmodic presented as an oral dosage form for oral use. It relieves abdominal cramping associated with irritable bowel syndrome and other functional bowel disorders.

GNH USA supplies Mebeverin Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mebeverine Hydrochloride acts on the gastrointestinal smooth muscle to alleviate spasm‑related conditions.

Irritable bowel syndrome: reduces abdominal pain and irregular bowel movements. Functional bowel disorders: eases discomfort caused by dysmotility. Abdominal cramping: diminishes intensity and frequency of cramps.

Mebeverine Hydrochloride may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Dry mouth - Headache - Dizziness - Abdominal discomfort - Constipation

Serious or Rare Side Effects: - Allergic reactions (rash, itching, swelling) - Severe skin rash or Stevens‑Johnson syndrome - Angioedema - Cardiac arrhythmia (rare) - Hepatotoxicity - Severe hypotension

Before prescribing Mebeverine Hydrochloride, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: safety unknown; weigh benefits against potential risks. - Renal impairment: use with caution and monitor renal function. - Elderly patients: monitor for increased sensitivity to side effects. - Drug interactions: review all concomitant medications. - Store at ambient temperature: keep in the original pack, protect from moisture.

Mebeverine Hydrochloride can interact with other medicines; assess potential risks.

Major Interactions (Avoid): - Concomitant use with other antispasmodics: risk of excessive smooth‑muscle relaxation. - Strong anticholinergic agents: additive antispasmodic effect may increase adverse events.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): may alter gastrointestinal motility. - Antihistamines: may increase dry‑mouth sensation. - Magnesium‑containing antacids: may affect drug absorption.